STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo targets tough blood cancers
Disease control CompletedThis study tested whether combining two drugs could help people with certain blood cancers that had returned after previous treatment or were newly diagnosed. The trial included 41 adults with chronic lymphocytic leukemia or similar conditions. Researchers gave participants an an…
Matched conditions: STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Drug aims to wipe out lingering cancer after initial treatment
Disease control CompletedThis study tested whether the drug ibrutinib could eliminate the last traces of cancer in patients with chronic lymphocytic leukemia (CLL) who had already responded to initial treatment but still had small amounts of disease left. Thirty-five patients took ibrutinib daily for up …
Matched conditions: STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC